Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Scotet

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Blood|January 15, 2011
Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cellsChristelle Harly, Marie-Alix Peyrat, Sonia Netzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturationMarie-Claire Devilder, Sophie Maillet, Isabelle Bouyge-Moreau, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 24, 2018
IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma TumorsNoémie Joalland, Cynthia Chauvin, Lisa Oliver, et al.
Oncoimmunology|October 25, 2019
Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells <i>in vivo</i>Noémie Joalland, Laura Lafrance, Thibauld Oullier, et al.
The Journal of Experimental Medicine|February 6, 2002
+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10Xavier Saulquin, Emmanuel Scotet, Lydie Trautmann, et al.
European Journal of Immunology|May 28, 2024
Camelid-derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agentsLola Boutin, Clément Barjon, Morgane Chauvet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2017
The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T CellsCassie-Marie Peigné, Alexandra Léger, Marie-Claude Gesnel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
V gamma 9V delta 2 T cell response to colon carcinoma cellsMurielle Corvaisier, Agnès Moreau-Aubry, Elisabeth Diez, et al.
European Journal of Immunology|May 28, 2020
Contribution of the SYK Tyrosine kinase expression to human iNKT self-reactivityJeanne Perroteau, Benjamin Navet, Marie-Claire Devilder, et al.
The Journal of Biological Chemistry|August 1, 2012
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodiesAparna Palakodeti, Andrew Sandstrom, Lakshmi Sundaresan, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Blood|January 15, 2011
Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cellsChristelle Harly, Marie-Alix Peyrat, Sonia Netzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturationMarie-Claire Devilder, Sophie Maillet, Isabelle Bouyge-Moreau, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 24, 2018
IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma TumorsNoémie Joalland, Cynthia Chauvin, Lisa Oliver, et al.
Oncoimmunology|October 25, 2019
Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells <i>in vivo</i>Noémie Joalland, Laura Lafrance, Thibauld Oullier, et al.
The Journal of Experimental Medicine|February 6, 2002
+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10Xavier Saulquin, Emmanuel Scotet, Lydie Trautmann, et al.
European Journal of Immunology|May 28, 2024
Camelid-derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agentsLola Boutin, Clément Barjon, Morgane Chauvet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2017
The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T CellsCassie-Marie Peigné, Alexandra Léger, Marie-Claude Gesnel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
V gamma 9V delta 2 T cell response to colon carcinoma cellsMurielle Corvaisier, Agnès Moreau-Aubry, Elisabeth Diez, et al.
European Journal of Immunology|May 28, 2020
Contribution of the SYK Tyrosine kinase expression to human iNKT self-reactivityJeanne Perroteau, Benjamin Navet, Marie-Claire Devilder, et al.
The Journal of Biological Chemistry|August 1, 2012
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodiesAparna Palakodeti, Andrew Sandstrom, Lakshmi Sundaresan, et al.
Pageof 7